A Phase 3, Randomized Study to Evaluate the Efficacy of Momelotimib Versus Best Available Therapy in Anemic or Thrombocytopenic Subjects with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post essential Thrombocythemia Myelofibrosis
Clinical Trial Grant
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Gilead Sciences, Inc.
Start Date
November 8, 2014
End Date
June 27, 2019
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Gilead Sciences, Inc.
Start Date
November 8, 2014
End Date
June 27, 2019